Back to Clinical Trials Overview

Your search for "Genetics" returned 27 results:


Studies of Urea Cycle Disorders: Oxidative Stress, Inflammation and the Acute Metabolic Decompensation
Principal Investigator(s): Diaz, George A

Biobank
Principal Investigator(s): Erwin Böttinger, MD

Double-Blind, Placebo-Controlled (Sham Surgery), Randomized, Multicenter Study Evaluating CERE-110 Gene Delivey in Subjects with Mild to Moderate Alzheimer's Disease
Principal Investigator(s): Neugroschl, Judith

The Genetics of Endophenotypes and Schizophrenia
Principal Investigator(s): Siever, Larry J

Genetic Determinants of Pheripheral arterial disease
Principal Investigator(s): Olin, Jeffrey W.

A Randomized, Double-Blind, 12-week, Parallel Group, Placebo-Controlled Study of the Efficacy and Safety of RO4917523 in Patients with Fragile X Syndrome
Principal Investigator(s): Alexander Kolevzon

a-Galactosidases A & B: Molecular & Cellular Mechanisms
Principal Investigator(s): Cohen-Pfeffer, Jessica

Building a Registry of Patients with Primary Immune Deficiency
Principal Investigator(s): Cunningham-Rundles, Charlotte

Genomics of Chronic Renal Allograft Rejection
Principal Investigator(s): Murphy, Barbara M.D.

Genetics Studies of Craniofacial and Limb
Principal Investigator(s): Jabs, Ethylin

Myozyme Temporary Access Program
Principal Investigator(s): Sivak, Mark

Advanced Glycation End Products (AGEs) and Alzheimer’s Disease
Principal Investigator(s): Schnaider-Beeri, Michal

Genetics & Neuroendocrinology of Short Stature
Principal Investigator(s): Rapaport, Robert

Genetic Markers Associated with Statin-Induced Myalgia and myopathy
Principal Investigator(s): Smith, Donald A MDMPH

Piloting Treatment with Insulin-Like Growth Factor-1 (IGF-1) in Phelan McDermid Syndrome
Principal Investigator(s): Alexander Kolevzon

Inflammation, long-term diabetes characteristics, and cognitive decline
Principal Investigator(s): Schnaider-Beeri, Michal

An Open-Label, Multicenter, Ascending Dose Study Of The Tolerability And Safety Of Recombinant Human Acid Sphingomyelinase (rhASM) In Patients With Acid Sphingomyelinase Deficiency (ASMD)
Principal Investigator(s): Melissa Wasserstein, MD

Molecular & Enzymatic Inherited Metabolic Diseases
Principal Investigator(s): Diaz, George A

Haptoglobin Genotype and Diabetes Mellitus in the Development of Atherosclerosis
Principal Investigator(s): Moreno, Pedro

Clarification of Optimal Anticoagulation through Genetics (COAG)
Principal Investigator(s): Desnick, Robert J.

Niemann-Pick Disease:Genotype/Phenotype Analysis
Principal Investigator(s): Melissa Wasserstein, MD

Beta Blocker Therapy vs. Angiotensin II in Marfan
Principal Investigator(s): Gelb, Bruce D M.D.

Long-term Extension of a Phase 2, Open-Label Dose-Finding Study to Evaluate the Safety, Efficacy, and Tolerability of Multiple Subcutaneous Doses of rAvPAL-PEG in Subjects with PKU (BioMarin Pharmaceutical Inc. Protocol PAL-003)
Principal Investigator(s): Melissa Wasserstein, MD

A randomized, parallel-group, double-blind, placebo-controlled, safety and exploratory efficacy and pharmacokinetic study of R04917523 in pediatric patients with Fragile X Syndrome
Principal Investigator(s): Alexander Kolevzon

Porphyria Rare Disease Clinical Research Consortium (RDCRC)
Principal Investigator(s): Desnick, Robert J.

Disflynisal on Familial Amyloidosis
Principal Investigator(s): Gorevic, Peter

Genetics Studies of Moebius Syndrome
Principal Investigator(s): Jabs, Ethylin